注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
AC Immune SA 是一家位於瑞士的臨床階段生物製藥公司。該公司專注於神經退行性疾病的精準醫療。它設計、發現和開髮用於預防、診斷和治療由錯誤折疊蛋白質引起的疾病的治療和診斷產品。其SupraAntigen和Morphomer技術平台可創建抗體、小分子和疫苗,旨在解決廣泛的神經退行性適應症,例如阿爾茨海默病 (AD)。該公司的管道包括九個治療候選產品,其中五個在臨床試驗中,以及三個診斷候選產品。其主要候選產品是Crenezumab,一種用於治療阿爾茨海默病的人源化單克隆抗 Abeta 抗體。它與製藥公司合作,包括 Roche/Genentech、Eli Lilly、Biogen、Janssen Pharmaceuticals、Nestle Institute of Health Sciences、Life Molecular Imaging(原名:Piramal Imaging)和 Essex Bio-Technology。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Andrea Pfeifer | 64 | 2003 | Co-Founder, CEO & Director |
Claude Nicolau | - | - | Member of Scientific Advisory Board |
M. Monsigny | - | - | Member of Scientific Advisory Board |
Alf E. A. Lindberg | 81 | - | Member of Scientific Advisory Board |
Fred Van Leuven | - | - | Member of Scientific Advisory Board |
E. M. Voisin Lestringant | - | - | Member of Scientific Advisory Board |
I. Rosenberg | - | - | Member of Scientific Advisory Board |
Detlev H. Riesner | 79 | 2004 | Member of Scientific Advisory Board |
Douglas Edward Williams | 65 | 2018 | Independent Non-Executive Chairman |
Pierre N. Tariot | - | - | Member of Clinical Advisory Board |
Werner Lanthaler | 55 | 2018 | Independent Non-Executive Director |
Lon S. Schneider | - | - | Member of Clinical Advisory Board |
Monica Shaw | 44 | 2021 | Independent Non-Executive Director |
Roy Twyman | 66 | 2019 | Independent Non-Executive Director |
Juan Fortea | - | 2020 | Member of Clinical Advisory Board |
Carl H. June | 69 | 2020 | Independent Non-Executive Director |
Reisa Sperling | - | - | Member of Clinical Advisory Board |
Murat Emre | - | - | Member of Clinical Advisory Board |
Jean-Marie Pierre Lehn | 85 | - | Chairman of Scientific Advisory Board |
Monika Butler | 63 | 2021 | Independent Vice Chair |
Andreas Monsch | - | - | Head of Clinical Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核